# OnCo record remegen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/remegen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "remegen" ;
  schema:name "RemeGen"@en ;
  schema:description "RemeGen developed disitamab vedotin, China's first domestic ADC."@en ;
  schema:url <https://onco.cc/companies/remegen/>, <https://www.remegen.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.remegen.com> ;
  schema:addressCountry "CN" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:drugs <https://onco.cc/drugs/disitamab-vedotin/> ;
  onco:trials <https://onco.cc/trials/nct07462143/>, <https://onco.cc/trials/nct06962865/>, <https://onco.cc/trials/nct06155396/>, <https://onco.cc/trials/nct05980481/>, <https://onco.cc/trials/nct05302284/>, <https://onco.cc/trials/nct06155383/>, <https://onco.cc/trials/nct06227117/>, <https://onco.cc/trials/nct06389006/>, <https://onco.cc/trials/nct06038396/>, <https://onco.cc/trials/nct06221748/>, <https://onco.cc/trials/nct06178159/>, <https://onco.cc/trials/nct06378242/>, <https://onco.cc/trials/nct06157892/>, <https://onco.cc/trials/nct07105215/>, <https://onco.cc/trials/nct07315750/>, <https://onco.cc/trials/nct05911295/>, <https://onco.cc/trials/nct06016062/>, <https://onco.cc/trials/nct05205850/>, <https://onco.cc/trials/nct06642545/> .